2011 Biennial Advisory Council Report Certifying Compliance with Inclusion Guidelines The National Institute on Drug Abuse (NIDA) Advisory Council has reviewed the implementation of the National Institutes of Health (NIH) Guidelines for inclusion of 2 w 0 o 1 me 1. n T a h n e d C minoriti Guidelines. ouncil de e t s e i r n mi cl n in e i d ca th lr a e t s N e I a D rc A h h ,f a o s ll s o u w cc in es g s i f t u s l me ly imp etin le g me on n Feb ted ru th a e ry se 2 N , IH F Amo mi Y09 n a g n t d he FY d 1 ocumen nority perce 0 n e t x a t g r e a t mu s re ra v l ie e w nr e o d ll b me yN n I t D d A at Ad af v o i r so N ry Council were tables showing 30.4%. Hispanic/Lat p in a o rt resea icipat rch ion p in art re icip sea a r n c t h s i a n re F IH Y0 a 9 nd w N as ID 29.9 A. T % he an o d ve in ra FY ll N 10 ID mi w A not included in n as c considered an et alculations. Acc hnicit ordin y and not g to the U a race. In FY09, Hispanic/Lat .S. Census Bureau, Hispanic/L ino sub atino in ject d o i r v ity constituted 12.1% of s iduals are su fema bje l c e ts , 48.1 constituted 12.1% NIDA’s as ex w tr el amural enr % male and 6.9% unk l n . ow Gen n d . e The rd o a l t lme a fo n r t. N I I n D F A Y s 1 h 0 o , w Hi i s n p F an Y i 0 c 9 /L 45.0 atin % o 48.0 • % ma FY10 data for NIDA was 46.3% female, • I T n h le and 5.7% unk F e Y N 0 I 9 H ,H minority p n e ow rce n n . tage The corresponding da in FY09 was 30.2% t and a for i NI nF H Y1 are 0 was as fol 3 l 2 ow .1% s: . • H In is F p Y a 0 n 9 ic , / N L is a p ti a n n o ic e / n L r a o t l i l n me oe n n t rollment was 7.4% and in FY10, the unknown s I ex/gend H total e er nr . In F ollme Y1 n w tw as a 1 s 5 5 . 9 7 . % 8% . 0, NIH female, 39.6% male, and 0.7% 43.0%male, and 0.9% unknown sex/ total gend e e n r. rollment was 56.1% female, H rep uma resen n su t b 17. jec 7 t % se o n f r N ol I l D ed A’ i s n e N n I r D o A lle P d h e a x s t e ra II mu I Cl r i a n l ic s a u l b T je r c ia ts ls . , In re F fl Y ected in FY09 data, in percent Clinical Tria age of NIH Pha ls represented se III Cl 14.4% inica of N l Tria IDA’s ls ca enr nb olle ea d t e t x rib tra ut mu ed t ra 1 l 0 s , u N b I j D e A cts P . h The drop ase III no longer Phase III C r l epor inica ting l Tri t a h ls ei f r ro e m nr N ol I l D me A’ n s t C . l S in e i c c o a n l d T , r F ia Y l 2 s 0 N 1 e 0 tw is o t r h k e ha o a few factors. First fir v s e t c y l e o a s r ed th a a n t d w w e e ha a v r e e , R en e e r in o v ll e me stme nt rep nrollment. n The FY t Ac or t ti o n f g 2 f 0 r 0 o 9 m ( t AR he R g A) ra . nt AR s awarded under the American Recovery and volunteers enrolled 09 da were t mi a for NID noritie A sa Ph R a A se gr I a II n C ts lin ac ic c a o l u T n r t ia fo ls r a 4 l . s 7 o % sh o o f w NI 11.8 DA’s % to of tal t nd 34.4% were female, 36.2% were male, an he 29.4% d i 3 n 4 c . were e u , nk l 5 u % femal 36 now .9% n ma sex le /gender and 28. . The F 6% unk Y10 data show nown. The repo 11 rt .9% ing mi of n Pha ori se tie I s II an gra d nts i a n tt fo ri r b d u e t s ed av to er a y la h r ig g h e, n 3 u 5 mb ye e a r mation until 2001. This st r, o lo f udy incl n u g n i k t n u o d w in n al g s e t ne y r udes 22,799 individua u d d t a h n a d td e i t d hn n i o c t it r y e . This ca t n be sex/gender or unknown race/ethnicity. This accounts for 76.4% ls of unk por enrollme of the now unk n nt now enrollment. n
13
Embed
2011 Biennial Advisory Council Report Certifying · Microsoft Word - 2011 Biennial Advisory Council Report Certifying.docx
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
2011 Biennial Advisory Council Report Certifying Compliance with Inclusion Guidelines The National Institute on Drug Abuse (NIDA) Advisory Council has reviewed the implementation of the National Institutes of Health (NIH) Guidelines for inclusion of
nority perce0n etxatgreatmus reravli eewnreodl lbmey NnItD dA atAda fvoirs oNry Council were tables showing
30.4%. Hispanic/Lat pinao rtreseaicipat
rch ion
pina rtreicipseaarncths ianre FIHY0 a9n dw NasI D29.9A. T
% hea nod veinra FYll N10 ID
miwA
not included in nas
cconsidered an etalculations. Acc
hnicitordin
y and notg to the U
a race. In FY09, Hispanic/Lat.S. Census Bureau, Hispanic/L
ino subatino in
jectdoirvity
constituted 12.1% of s iduals are
sufemabjelcets, 48.1 constituted 12.1%
NIDA’sa s exwtrelamural enr
% male and 6.9% unkln. owGennd. eThe r doaltlmea fonrt .N IInD FA Ys1h0o, wH iisnp FanYi0c9/ L45.0atin
% o
48.0•% ma
FY10 data for NIDA was 46.3% female,
• ITnhle and 5.7% unk
Fe YN0I9H, Hminority p
neowrcenn.t age The corresponding da
in FY09 was 30.2%t anda for
i NIn FH Y 1are 0 wasas fol
3l2ow.1%s: .
• HIni sFpYa0n9ic, /NLisaptiannoi ce/nLraotlilnmeo enntrollment was 7.4% and in FY10, the
unknown sIex/gendH total e
ernr. In Follme
Y1n wt wasa 1s 55.97.%8%.
0, NIH female, 39.6% male, and 0.7%
43.0%male, and 0.9% unknown sex/
total gend
eenr.r ollment was 56.1% female,
Hrepumaresenn sut b17.jec7t%s e onfr NolIlDedA’ isn e NnIrDoA llePdh eaxster aIImuI Clrianli csaulb Tjerciatsls. ,I nre FflYected in FY09 data,
in percentClinical Tria
age of NIH Phals represented
se III Cl14.4%
inica of N
l TriaIDA’s
ls ca enr
n bollee ad tetxribtrautmued tra1l0 s, uNbIjDeA ctsP.h The drop ase III
no longerPhase III C
rleporinica
ting l Tri
tahlse ifrr oem nrNolIlDmeA’ns tC. l Sineiccoanl dT,r FiaYl2s 0N1e0tw iso trhke ha
o a few factors. First
firvset cyleoasre dth aant dw we eh aavree,
Ren
eerinovllemestment rep
nrollment. n The FYt Acortt ionfg 2 f0r0o9m (tARheR gA)ra.n tARs awarded under the American Recovery and
volunteers enrolled09 da were
t mia for NIDnoritie
A s aPhRaA seg rIaIIn Ctsli naciccaolu Tnrti afolsr a4l.s7o% s hoof wN I11.8DA’s
% toof talt
nd 34.4% were female, 36.2% were male, anhe
29.4% d
i3n4c.
were eu,nk
l5u% femal 36
now.9%
n masexle/ genderand 28.
. The F6% unk
Y10 data show nown. The repo
11rt.9%ing miof nPhaorise tieIsI Ia ngrad nts
ianttforirbduetse da vtoe ray l ahrigghe , n3u5mb yeear
mation until 2001. This str ,o lof
udy inclnugniktnuodwinna lg setn eyr
udes 22,799 individuaudd t
ahnadt deitdh nniocti trye. This ca
t n be
sex/gender or unknown race/ethnicity. This accounts for 76.4% ls of unkpor enrollme
of the nowunknnt
now
enrollment. n
NIDA’s Intramural Research Program (IRP) is located in Baltimore, MD. In FY09, African Americans comprised 58.3% of research subjects. The minority enrollment
Affor ritche anI AmeRP w
raics 61.9%. Females comprised 40.4% of the subjects in FY09. In FY10,
mi nority enroll
amensn cto wmpasr 64.3ised
%61.4. F%ema ofl eres sceoamprchr issuebdj e40.4cts a
% t Nof IDsuA’bsj ectIRPs . in T hFYe 10.tota l
rTo helepres
p ensure entation
tahraet i mpthe
l NemeIH nreteqdu ibrye meNIDnA,ts relating t
not issue a non-‐competing (type 5) grant a twhaer Gdr uann
y
ttos miMannorit /gender
il the miagneomeritnyt/ Sgpeencdiearli sstesc twioilnl of
it
nhfeo Prmarogtriaom n fOorff eicaicahl’ sg Prarnotg raensds pRreoptoorcto is presentl.
and contains all required
“TWheo meGovne’sr nHmeealntth Ac – counting Organization (GAO) Audit of May 2000, entitled
rreeqcoummeireme
nndte tdh tahta pth “NtIhHe hDairse Icntcorre oafs eNdI Hit s Efforts to Include Women in Research,”
the valid analysis of dasifef eIrIIe nclciensic bael ttwrieaelsn ebnes duersei gthnaatt ethe agency impleme
women and dme annd a csa frurlileyd a osu itt nts the
ito all
other mple
omew fnotrs
NanIHd rTerealecmekinngt asn odt hInerc leulseimeon nCtosmmi of th
tete ien cislu rseisopn policy.” The
porting this information. NIDA Program oOnfsfiibcilael sfo rre cso NlleIDctA inrge,p resentative to
clinical trial grants continue to be informed of, and are imppleomensinbtlien fcooro Prhdainsaet IiInIg ,
creliqnuiciarel metrianlst eampre i
hdaesnitziefid in the GAO recommendation. As additional
g P thhaes e III
rdeepterremisenntaattiiovne tthoa tth teh Ne IpHed T, rtahcek ainpgp raonpdr Iiantcelu Psrioognr Caom mmiOffi
tctieaels r aenvide wth eth NeI IDRA G’s
rreessptso wnsitibhi tlihtey Ifnors NIDA imp
rojelecmet innvtoaltvieosn ao Pf NhaIHse mi IIIn colirnitiyc/alg tria
titute Deputy Director. He is assisted by NeInl. U
DdA’ers plotilmaicyt aet N
Inclusion CoNIH Tracki
InDgA and
iMnaclnuadgienmeg Sncimmientif
titec Re Reevpresentative. On a day-‐to-‐day basis, many individuals,
pecific grants. ticniga ltsh, ea npdo lGicriaenst asn d
TAsra ocfk Ninogv aenmbd Ienrc 2lu0s0io4n, C Chormmiistie
tEtesep.i n Mosz.a E hsapsi nboezean h NaIsD bA’ees representa
of Extramural Research and the NIH Tracking and Inclusionn w Coormmiking
e
t wtiivth tto the NIH
tee to heen Osuffriec e
ath
rllat th gove
er FnY0me9n andt re
gFuYla1t0
egulations Program Ofifo dnast.a T tora ecnksiunrge h aulmal Nn subject research is in compliance with
and resources via e-‐maili crieallast iwnigt hto h puomalicny sIuDbA jesctta gffr aisn itns choampveliance with these
women and minorities in research. Each Praongdr arm eguOlfafitcioianls w, coo
ee
rn bcern
n sent informatio
ks diriencgt leyn wroitlhlme Msn.t onf
Espinoza to ensure that their grants meet the policy and regulation requirements.
DaEsptain enoztary , Qinuato ndthe ra Spcopududlaetrion, Ai dtraa Kckluinng, adnadta Dboansen aw Iansma penrf. o Trmehe dda btya Cenhtrrisyt sieta ff met
four times over the last two years to hold refresher training on the policy as well as technical issues related to maintaining this data for NIDA.